Semaglutide supply tightens; compounding pharmacies face increased scrutiny. Three of eight vendors tested in Q1 failed purity benchmarks.
Signal: coming soon
Quarterly market briefings, trend analysis, vendor movement, and what changed across the catalog, will be included with the Signal plan when it launches.